Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery

Phase 3 Completed 135 enrolled Ethicon, Inc. OMRIX Biopharmaceuticals · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

A comparison of fibrin sealant 2 versus Surgicel® as an addition to standard surgical practice in stopping mild to moderate soft tissue bleeding during retroperitoneal or intra-abdominal surgery.

Timeline

Start: 2006-02
Primary completion: 2006-12
Completion: 2006-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fibrin Sealant 2	Protein / enzyme biologic	—	—

Indications

No indication recorded.